“The acquisition represents a significant and synergistic addition to our concentrated portfolio of CNS products ... Pharma acquires Reminyl from Janssen Pharmaceutica" was originally created ...

Johnson & Johnson subsidiary Janssen Pharmaceutica has licensed a range of drug candidates to BenevolentAI, a UK-based artificial intelligence company. The deal will make use of BenevolentAI’s ...